Hiroaki Kuroda

3.9k total citations
194 papers, 2.5k citations indexed

About

Hiroaki Kuroda is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Hiroaki Kuroda has authored 194 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pulmonary and Respiratory Medicine, 62 papers in Surgery and 49 papers in Oncology. Recurrent topics in Hiroaki Kuroda's work include Lung Cancer Diagnosis and Treatment (65 papers), Lung Cancer Treatments and Mutations (48 papers) and Lung Cancer Research Studies (19 papers). Hiroaki Kuroda is often cited by papers focused on Lung Cancer Diagnosis and Treatment (65 papers), Lung Cancer Treatments and Mutations (48 papers) and Lung Cancer Research Studies (19 papers). Hiroaki Kuroda collaborates with scholars based in Japan, United States and Italy. Hiroaki Kuroda's co-authors include Yukinori Sakao, Yasushi Yatabe, Noriaki Sakakura, Toyoaki Hida, Yuko Oya, Yoshitsugu Horio, Junichi Shimizu, James A. Fagin, Tatsuya Yoshida and Jeffrey A. Knauf and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hiroaki Kuroda

178 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Kuroda Japan 26 1.1k 846 537 408 276 194 2.5k
Yusuke Inoue Japan 22 510 0.5× 686 0.8× 744 1.4× 457 1.1× 197 0.7× 148 2.2k
Christopher R. Pierson United States 31 366 0.3× 499 0.6× 1.1k 2.1× 415 1.0× 96 0.3× 103 2.9k
Jacob Freedman Sweden 27 609 0.5× 726 0.9× 372 0.7× 1.0k 2.5× 101 0.4× 78 2.5k
Ronald P. Kaufman United States 30 1.4k 1.3× 467 0.6× 670 1.2× 831 2.0× 57 0.2× 78 3.2k
S. Baba Japan 27 497 0.4× 705 0.8× 739 1.4× 969 2.4× 195 0.7× 149 2.8k
Hiroshi Inoué Japan 29 793 0.7× 490 0.6× 1.0k 1.9× 652 1.6× 54 0.2× 188 3.2k
Narihito Seki Japan 31 803 0.7× 370 0.4× 654 1.2× 464 1.1× 52 0.2× 134 3.4k
Pierluigi Di Sebastiano Italy 27 364 0.3× 969 1.1× 639 1.2× 974 2.4× 128 0.5× 70 2.3k
Knut Lote Norway 26 711 0.6× 515 0.6× 328 0.6× 227 0.6× 134 0.5× 60 2.6k
Dong Wu China 27 786 0.7× 902 1.1× 586 1.1× 1.2k 2.8× 39 0.1× 72 3.1k

Countries citing papers authored by Hiroaki Kuroda

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kuroda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kuroda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kuroda more than expected).

Fields of papers citing papers by Hiroaki Kuroda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kuroda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kuroda. The network helps show where Hiroaki Kuroda may publish in the future.

Co-authorship network of co-authors of Hiroaki Kuroda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kuroda. A scholar is included among the top collaborators of Hiroaki Kuroda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kuroda. Hiroaki Kuroda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shirasawa, Masayuki, Tatsuya Yoshida, Takaji Matsutani, et al.. (2025). Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLC. npj Precision Oncology. 9(1). 17–17. 1 indexed citations
2.
Masago, Katsuhiro, Hiroaki Kuroda, Eiichi Sasaki, et al.. (2024). Novel gene fusions in human oropharyngeal carcinoma. Cancer Genetics. 286-287. 29–34.
3.
Yamaguchi, Teppei, Katsuhiro Masago, Eiichi Sasaki, et al.. (2023). EML4-ALK Variant 3a/b as a mechanism of osimertinib resistance in a patient with EGFR L858R positive NSCLC. Cancer Genetics. 280-281. 13–16.
4.
Heymach, John V., David H. Harpole, Tetsuya Mitsudomi, et al.. (2023). Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC. Cancer Research. 83(8_Supplement). CT005–CT005. 55 indexed citations
5.
Chen, Chao, Duilio Divisi, Marcello Migliore, et al.. (2023). Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study. Translational Lung Cancer Research. 12(5). 1078–1092. 1 indexed citations
6.
Horio, Yoshitsugu, Hiroaki Kuroda, Katsuhiro Masago, et al.. (2023). Current diagnosis and treatment of salivary gland-type tumors of the lung. Japanese Journal of Clinical Oncology. 54(3). 229–247. 4 indexed citations
7.
8.
Sasaki, Eiichi, Shiro Fujita, Hiroaki Kuroda, et al.. (2023). Mucous Gland Adenoma of the Lung: A Neoplastic Counterpart of Mucinous Bronchial Glands. Modern Pathology. 36(6). 100182–100182. 6 indexed citations
9.
Shiono, Satoshi, Noriyuki Matsutani, Hiroshi Hashimoto, et al.. (2021). Prospective study of recurrence at the surgical margin after wedge resection of pulmonary metastases. General Thoracic and Cardiovascular Surgery. 69(6). 950–959. 10 indexed citations
10.
Haneda, Masataka, Katsuhiro Masago, Shiro Fujita, et al.. (2020). Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF. Pathology International. 70(5). 253–261. 13 indexed citations
11.
Dejima, Hitoshi, Hayao Nakanishi, Hiroaki Kuroda, et al.. (2018). Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform. Lung Cancer. 125. 128–135. 16 indexed citations
12.
Ikematsu, Yoshito, et al.. (2009). A Study on the Advanced Rectal Cancer treated with Neoadjuvant Chemoradiation. The Japanese Journal of Gastroenterological Surgery. 42(3). 238–246.
13.
Kuroda, Hiroaki, et al.. (2004). [Double valve replacement for infective endocarditis following osteomyelitis; report of two cases].. PubMed. 57(1). 83–5. 1 indexed citations
14.
Ikematsu, Yoshito, et al.. (2004). Descending Colon Cancer Associated with Intussusception-Report of a Case-. The Japanese Journal of Gastroenterological Surgery. 37(10). 1664–1667. 2 indexed citations
15.
Kamihira, S, et al.. (2001). The Effects of Rewarming Speed on Cerebral Circulation and Oxygen Metabolism during the Rewarming Period of Cardiopulmonary Bypass.. Japanese Journal of Cardiovascular Surgery. 30(1). 1–6.
16.
Kuroda, Hiroaki, et al.. (2001). A Case of Aortic Root Remodeling for Aneurysm of the Noncoronary Sinus of Valsalva.. Japanese Journal of Cardiovascular Surgery. 30(5). 252–254. 1 indexed citations
17.
Morimoto, Keisuke, Shingo Ishiguro, & Hiroaki Kuroda. (1997). Release of Brain Natriuretic Peptide during the Perioperative Period of Cardiac Surgery. Yonago acta medica. 40(1). 1–11. 3 indexed citations
18.
Kuroda, Hiroaki, et al.. (1995). Aortic Dissection Associated with Atherosclerotic Aortic Aneurysm.. Japanese Journal of Cardiovascular Surgery. 24(1). 1–5. 1 indexed citations
19.
Ishiguro, Shingo, et al.. (1994). Open Heart Surgery Using a Centrifugal Pump in a Patient Suffering from Hereditary Spherocytosis.. Japanese Journal of Cardiovascular Surgery. 23(4). 280–283. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Inoue Breakdown of academic impact, for papers by Christopher R. Pierson Breakdown of academic impact, for papers by Jacob Freedman Breakdown of academic impact, for papers by Ronald P. Kaufman Breakdown of academic impact, for papers by S. Baba Breakdown of academic impact, for papers by Hiroshi Inoué Breakdown of academic impact, for papers by Narihito Seki Breakdown of academic impact, for papers by Pierluigi Di Sebastiano Breakdown of academic impact, for papers by Knut Lote Breakdown of academic impact, for papers by Dong Wu
Rankless by CCL
2026